Literature DB >> 19882379

Cancer screening practices among racially and ethnically diverse breast cancer survivors: results from the 2001 and 2003 California health interview survey.

Erica S Breslau1, Diana D Jeffery, William W Davis, Richard P Moser, Timothy S McNeel, Sarah Hawley.   

Abstract

INTRODUCTION: Women treated for breast cancer are at increased risk for developing second or new cancers. This study examined behavioral and health care utilization practices associated with screening behaviors for mammography, Papanicolaou (Pap), home fecal occult blood test (FOBT) and endoscopy (flexible sigmoidoscopy, colonoscopy, proctoscopy) among racially and ethnically diverse female breast cancer survivors (BCS) and women without a cancer history.
METHODS: Data from the 2001 and 2003 California Health Interview Survey (CHIS), a random-digit dial population-based survey of adult respondents was used to examine self-reported screening practices of BCS (n = 1,502) and women without a cancer history (n = 31,911).
RESULTS: Compared to women without a cancer history, BCS reported more recent screening for all tests. Among BCS, Hispanics reported lowest screening for routine mammography (84.2% versus 68.9%; P < 0.05) but highest screening for Pap test (95.4% versus 85.4%; P > 0.01). White and Asian BCS reported more endoscopic examinations (58.9% versus 46.5%; P < 0.001; 61.2% versus 38.4%; P < 0.05) than the comparison population. After adjustment for demographic, socioeconomic, and health status differences, screening rates for BCS showed higher mammography use (odds ratio [OR] 1.97; 95% confidence interval [95% CI] 1.58-2.46), Pap test (OR 1.44; 95% CI 1.22-1.70), and endoscopic use (OR 1.35; 95% CI 1.16-1.58), but not higher for FOBT.
CONCLUSIONS: Even though BCS generally had higher cancer screening rates than women without a cancer history, racial/ethnic differences exist among the type of test received. Narrowing these differences is essential to lessen disparities. IMPLICATIONS FOR CANCER SURVIVORS: The need for screening guidelines for BCS remains a high priority. Survivors would benefit from the frequency of screening for all cancers post-treatment.

Entities:  

Mesh:

Year:  2009        PMID: 19882379     DOI: 10.1007/s11764-009-0102-5

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  49 in total

1.  Breast and cervical cancer screening rates of subgroups of Asian American women in California.

Authors:  Marjorie Kagawa-Singer; Nadereh Pourat; Nancy Breen; Steven Coughlin; Teresa Abend McLean; Timothy S McNeel; Ninez A Ponce
Journal:  Med Care Res Rev       Date:  2007-09-05       Impact factor: 3.929

2.  A framework for the study of access to medical care.

Authors:  L A Aday; R Andersen
Journal:  Health Serv Res       Date:  1974       Impact factor: 3.402

3.  Impact of U.S. citizenship status on cancer screening among immigrant women.

Authors:  Israel De Alba; F Allan Hubbell; Juliet M McMullin; Jamie M Sweningson; Richard Saitz
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

4.  American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines.

Authors:  T J Smith; N E Davidson; D V Schapira; E Grunfeld; H B Muss; V G Vogel; M R Somerfield
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

5.  Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment.

Authors:  Jeanne S Mandelblatt; William F Lawrence; Jennifer Cullen; Annette L Stanton; Janice L Krupnick; Lorna Kwan; Patricia A Ganz
Journal:  J Clin Oncol       Date:  2006-01-01       Impact factor: 44.544

6.  14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening.

Authors:  F E Alexander; T J Anderson; H K Brown; A P Forrest; W Hepburn; A E Kirkpatrick; B B Muir; R J Prescott; A Smith
Journal:  Lancet       Date:  1999-06-05       Impact factor: 79.321

7.  Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey.

Authors:  M Hewitt; N Breen; S Devesa
Journal:  J Natl Cancer Inst       Date:  1999-09-01       Impact factor: 13.506

8.  Quality of non-breast cancer health maintenance among elderly breast cancer survivors.

Authors:  Craig C Earle; Harold J Burstein; Eric P Winer; Jane C Weeks
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

9.  Prediction of the long-term survival in breast cancer patients according to the present oncological status.

Authors:  Laurence Hatteville; Cédric Mahe; Catherine Hill
Journal:  Stat Med       Date:  2002-08-30       Impact factor: 2.373

10.  Rates and predictors of colorectal cancer screening.

Authors:  Su-Ying Liang; Kathryn A Phillips; Mika Nagamine; Uri Ladabaum; Jennifer S Haas
Journal:  Prev Chronic Dis       Date:  2006-09-15       Impact factor: 2.830

View more
  14 in total

1.  Racial and socioeconomic disparities in adherence to preventive health services for ovarian cancer survivors.

Authors:  Lacey Loomer; Kevin C Ward; Evelyn A Reynolds; Silke A von Esenwein; Joseph Lipscomb
Journal:  J Cancer Surviv       Date:  2019-06-06       Impact factor: 4.442

2.  Validation of self-reported post-treatment mammography surveillance among breast cancer survivors by electronic medical record extraction method.

Authors:  Jasmin A Tiro; Joanne M Sanders; L Aubree Shay; Caitlin C Murphy; Heidi A Hamann; L Kay Bartholomew; Lara S Savas; Sally W Vernon
Journal:  Breast Cancer Res Treat       Date:  2015-04-29       Impact factor: 4.872

3.  Ethnic disparities in adherence to breast cancer survivorship surveillance care.

Authors:  Pragati S Advani; Jun Ying; Richard Theriault; Amal Melhem-Bertrand; Stacy Moulder; Isabelle Bedrosian; Welela Tereffe; Shon Black; Tunghi May Pini; Abenaa M Brewster
Journal:  Cancer       Date:  2013-11-20       Impact factor: 6.860

4.  Multi-level Influences on Breast Cancer Screening in Primary Care.

Authors:  Tracy Onega; Tor D Tosteson; Julie Weiss; Jennifer S Haas; Martha Goodrich; Roberta DiFlorio; Charles Brackett; Cheryl Clark; Kimberly Harris; Anna N A Tosteson
Journal:  J Gen Intern Med       Date:  2018-08-03       Impact factor: 5.128

5.  Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.

Authors:  Melissa Y Carpentier; Jasmin A Tiro; Lara S Savas; L Kay Bartholomew; Trisha V Melhado; Sharon P Coan; Keith E Argenbright; Sally W Vernon
Journal:  J Cancer Surviv       Date:  2012-12-18       Impact factor: 4.442

6.  An analysis of the association between cancer-related information seeking and adherence to breast cancer surveillance procedures.

Authors:  Andy S L Tan; Mihaela Moldovan-Johnson; Stacy W Gray; Robert C Hornik; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-11-01       Impact factor: 4.254

7.  Multilevel determinants of financial toxicity in breast cancer care: perspectives of healthcare professionals and Latina survivors.

Authors:  Perla Chebli; Jocelyne Lemus; Corazón Avila; Kryztal Peña; Bertha Mariscal; Sue Merlos; Judith Guitelman; Yamilé Molina
Journal:  Support Care Cancer       Date:  2019-11-12       Impact factor: 3.603

8.  Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia.

Authors:  M Corkum; R Urquhart; G Kephart; J A Hayden; G Porter
Journal:  Curr Oncol       Date:  2014-10       Impact factor: 3.677

Review 9.  Racial/ethnic disparities in use of surveillance mammogram among breast cancer survivors: a systematic review.

Authors:  Pragati Advani; Shailesh Advani; Pratibha Nayak; Helena M VonVille; Pamela Diamond; Jason Burnett; Abenaa M Brewster; Sally W Vernon
Journal:  J Cancer Surviv       Date:  2021-05-13       Impact factor: 4.442

10.  Cancer surveillance and preventive services in a diverse sample of breast and colorectal cancer survivors.

Authors:  Beth A Glenn; Narissa J Nonzee; Ann S Hamilton; Lina Tieu; Annette E Maxwell; Catherine M Crespi; L Cindy Chang; Dennis Deapen; Roshan Bastani
Journal:  J Cancer Surviv       Date:  2020-08-14       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.